Evidence map›Paper›PMID 40463806›Full record

ArticleClinical kidney journal2025

Occurrence and prognosis of chronic kidney disease in Denmark - a nationwide population-based cohort study.

Simon Kok Jensen, Michael Bertelsen, Søren Viborg Vestergaard, Mette Nørgaard, Reimar Wernich Thomsen, Henrik Birn, Uffe Heide-Jørgensen, Christian Fynbo Christiansen

Abstract read
In one paragraph

Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Parathyroid hormone and alkaline phosphatase are associated with fracture risk in non-dialysis-dependent chronic kidney disease.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Simon Kok JensenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-0032-131X
Michael BertelsenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Søren Viborg VestergaardDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-8445-7758
Mette NørgaardDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0001-6110-5891
Reimar Wernich ThomsenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0001-9135-3474
Henrik BirnDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID https://orcid.org/0000-0003-3715-7266
Uffe Heide-JørgensenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Christian Fynbo ChristiansenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-0727-953X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Information on chronic kidney disease (CKD) epidemiology is essential for healthcare provision. Moreover, variation in CKD occurrence and prognosis may reveal unwarranted inequalities in healthcare. Therefore, we examined the nationwide incidence, prevalence, and mortality of laboratory-confirmed CKD in Denmark and assessed variation according to urbanicity. Methods: This nationwide cohort study utilized population-based laboratory data on estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (uACR) and included all adult (≥18 years) Danish residents without prevalent CKD on 1 January 2019. We estimated crude and standardized incidence rates, prevalences, and mortality rates of CKD overall and according to urbanicity categories. We standardized by age and sex, and by age, sex, diabetes, hypertension, and outpatient eGFR and uACR testing frequency. Results: The study included 4 157 059 adult Danish residents of whom 281 985 developed incident CKD during the 5-year study period. The CKD incidence rate was 14.5 [95% confidence interval (CI), 14.4-14.5] per 1000 person-years, and the CKD prevalence was 9.5% (95% CI, 9.5%-9.5%). The 5-year mortality was 24.9% (95% CI, 24.5%-25.3%). The crude CKD incidence, prevalence, and mortality varied across urbanicity categories; however, differences were largely accounted for by standardizing for age and sex. Conclusions: Chronic kidney disease affected nearly one in ten adults in Denmark, and one in four individuals with incident CKD died within 5 years. The occurrence and prognosis of CKD varied across urbanicity categories and was predominantly related to differences in demographics. This emphasizes the need for a targeted allocation of healthcare resources according to population demographics.

Indexed as

chronic kidney diseasemortalityoccurrencepopulation healthprognosis

Identifiers

PMID40463806
PMCPMC12128079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.